Healthcare - Biotechnology - NASDAQ - US
$ 2.87
-13.3 %
$ 62.2 M
Market Cap
-0.93
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
19.87%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Aileron Therapeutics, Inc.
ALRN has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart ALRN
EBIT FORECAST
EBIT Forecast Chart ALRN
NET INCOME FORECAST
Net Income Chart ALRN